The authorities on Tuesday cancelled the licenses of 18 pharma companies for manufacturing of spurious medicines following the inspection by the Drugs Controller General of India (DCGI) on 76 companies across 20 States, official sources knowledgeable.
Apart from this, motion on 70 companies has been taken in Himachal Pradesh, 45 in Uttarakhand and 23 in Madhya Pradesh, sources mentioned.
They additional talked about that an enormous crackdown continues to be underway on a number of pharma companies across the nation associated to the manufacturing of spurious medicines.
Â
((*76*) to observe…)
ALSO READ |Â Opposition events prone to convey no-confidence movement towards Lok Sabha Speaker Om Birla: Report
